Figure 4
From: Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients
Clinical outcomes by IKZF1 alteration. IKZF1 alteration had a prognostic impact on overall survival (OS) and relapse-free survival (RFS) in child B-cell lymphoblastic leukemia/lymphoma (B-ALL), particularly in the good cytogenetic (Gcyto) and intermediate cytogenetic risk (Icyto) groups. Child B-ALL were classified into Gcyto (n = 26) and Icyto (n = 26) groups.
